162 related articles for article (PubMed ID: 28466054)
1. Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies.
Deeba F; Malik MZ; Naqvi IH; Haider MSH; Shafat Z; Sinha P; Ishrat R; Ahmed A; Parveen S
Virusdisease; 2017 Mar; 28(1):39-49. PubMed ID: 28466054
[TBL] [Abstract][Full Text] [Related]
2. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.
Mahish C; De S; Chatterjee S; Ghosh S; Keshry SS; Mukherjee T; Khamaru S; Tung KS; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2023; 14():1139808. PubMed ID: 37153546
[TBL] [Abstract][Full Text] [Related]
3. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
Verma J; Hasan A; Sunil S; Subbarao N
J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
[TBL] [Abstract][Full Text] [Related]
4. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
5. Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells.
de Oliveira DM; Santos IA; Martins DOS; Gonçalves YG; Cardoso-Sousa L; Sabino-Silva R; Von Poelhsitz G; Franca EF; Nicolau-Junior N; Pacca CC; Merits A; Harris M; Jardim ACG
Front Microbiol; 2020; 11():608924. PubMed ID: 33384677
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design.
Battini L; Fidalgo DM; Álvarez DE; Bollini M
ACS Infect Dis; 2021 Jun; 7(6):1503-1518. PubMed ID: 34048233
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry.
Sahoo B; Chowdary TK
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876
[TBL] [Abstract][Full Text] [Related]
8. Targeting Chikungunya Virus Entry: Alternatives for New Inhibitors in Drug Discovery.
Silva LR; Rodrigues ÉEDS; Taniele-Silva J; Anderson L; Araújo-Júnior JX; Bassi ÊJ; Silva-Júnior EFD
Curr Med Chem; 2022; 29(4):612-634. PubMed ID: 34165405
[TBL] [Abstract][Full Text] [Related]
9. In silico study on anti-Chikungunya virus activity of hesperetin.
Oo A; Hassandarvish P; Chin SP; Lee VS; Abu Bakar S; Zandi K
PeerJ; 2016; 4():e2602. PubMed ID: 27812412
[TBL] [Abstract][Full Text] [Related]
10. Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their
Agarwal G; Gabrani R
Protein Pept Lett; 2021; 28(5):508-519. PubMed ID: 33121397
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Molecular Surveillance of Chikungunya Virus.
Fischer C; de Lamballerie X; Drexler JF
mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein.
Verma J; Subbarao N
J Biomol Struct Dyn; 2023 May; 41(8):3349-3367. PubMed ID: 35272566
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach.
Agarwal G; Gupta S; Gabrani R; Gupta A; Chaudhary VK; Gupta V
Bioinformation; 2019; 15(6):439-447. PubMed ID: 31312082
[TBL] [Abstract][Full Text] [Related]
14.
Jain J; Kumari A; Somvanshi P; Grover A; Pai S; Sunil S
F1000Res; 2017; 6():1601. PubMed ID: 29333236
[No Abstract] [Full Text] [Related]
15. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
[TBL] [Abstract][Full Text] [Related]
16. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
[TBL] [Abstract][Full Text] [Related]
17. Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis.
Kim J; Yang J; Kim YB; Lee HJ; Kim S; Poo H
Virol Sin; 2019 Oct; 34(5):563-571. PubMed ID: 31214999
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of E2 region of Chikungunya virus circulating in Odisha, Eastern India from 2010 to 2011.
Sahu A; Das B; Das M; Patra A; Biswal S; Kar SK; Hazra RK
Infect Genet Evol; 2013 Aug; 18():113-24. PubMed ID: 23684629
[TBL] [Abstract][Full Text] [Related]
19. Identification of structural motifs in the E2 glycoprotein of Chikungunya involved in virus-host interaction.
Asnet Mary J; Paramasivan R; Tyagi BK; Surender M; Shenbagarathai R
J Biomol Struct Dyn; 2013 Oct; 31(10):1077-85. PubMed ID: 23025271
[TBL] [Abstract][Full Text] [Related]
20. Suramin Inhibits Chikungunya Virus Entry and Transmission.
Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
